Pyroptosis-Related Genes as Prognostic Biomarkers and Immune Infiltration Features in Sepsis-Induced ARDS: A Single-Cell and Bulk RNA-Sequencing Analysis

细胞焦亡相关基因作为脓毒症诱导的ARDS的预后生物标志物和免疫浸润特征:单细胞和批量RNA测序分析

阅读:1

Abstract

BACKGROUND: Sepsis-induced acute respiratory distress syndrome (ARDS) is a common and costly syndrome with high mortality and poor prognosis without targeted therapies. Recently, pyroptosis has been demonstrated to be an inflammatory form of programmed cell death. However, the expression of pyroptosis-related genes (PRGs) in sepsis-induced ARDS and their correlation with prognosis remain unclear. METHODS: In this study, 760 sepsis samples from public datasets were analyzed. We first conducted a comprehensive analysis of single-cell RNA-sequencing data of sepsis from the Gene Expression Omnibus database and identified 8 cell types and 38 hub genes. Subsequently, we used univariate Cox hazard analysis to narrow down the candidate genes and developed a prognostic model using the disease cohorts, which stratified patients into high- and low-risk groups. Four genes associated with the prognosis of patients with sepsis admitted to the intensive care unit for ≥ 28 days were identified. RESULTS: High-risk patients have lower proportions of activated CD8(+) T, effector memory CD8(+) T, and memory B cells. The majority of the immune cells were positively correlated with each other. However, there was a negative association between neutrophils and other factors. Importantly, correlations between prognostic genes and the corresponding immune cells revealed that CCL5, CD3G, and IL7R were significantly associated with activated CD8+ T cells, and GIMAP4 was significantly negatively correlated with immune cells. Multivariate analysis identified the risk score as an independent prognostic factor. CONCLUSION: PRGs play a significant role in sepsis immunity. The above four key genes (CCL5, CD3G, IL7R, and GIMAP4) are expected to serve as clinical diagnostic targets, providing a basis for clinical prognosis stratification in patients with sepsis-induced ARDS and guiding the formulation of individualized treatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。